ECSP12011630A - Formulación farmacéutica - Google Patents

Formulación farmacéutica

Info

Publication number
ECSP12011630A
ECSP12011630A ECSP12011630A ECSP12011630A EC SP12011630 A ECSP12011630 A EC SP12011630A EC SP12011630 A ECSP12011630 A EC SP12011630A EC SP12011630 A ECSP12011630 A EC SP12011630A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
Other languages
English (en)
Inventor
Jean-Pierre Burnouf
Tsiala Benard
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Priority to ECSP12011630 priority Critical patent/ECSP12011630A/es
Publication of ECSP12011630A publication Critical patent/ECSP12011630A/es

Links

ECSP12011630 2012-01-27 2012-01-27 Formulación farmacéutica ECSP12011630A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP12011630 ECSP12011630A (es) 2012-01-27 2012-01-27 Formulación farmacéutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP12011630 ECSP12011630A (es) 2012-01-27 2012-01-27 Formulación farmacéutica

Publications (1)

Publication Number Publication Date
ECSP12011630A true ECSP12011630A (es) 2012-02-29

Family

ID=52449853

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP12011630 ECSP12011630A (es) 2012-01-27 2012-01-27 Formulación farmacéutica

Country Status (1)

Country Link
EC (1) ECSP12011630A (es)

Similar Documents

Publication Publication Date Title
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
HRP20211423T4 (hr) Formulacije enzalutamida
DK2858671T3 (da) Antistofformulering
DK2890397T3 (da) Antiprolactinreceptor-antistofformulering
PT2854768T (pt) Composições farmacêuticas de pemetrexed
CO6940426A2 (es) Formulaciones farmacéuticas
DK2897594T3 (da) Farmaceutisk sammensætning
BR112014000015A2 (pt) formulação
DK2502622T3 (da) Farmaceutisk formulering omfattende inositol
DK2868318T4 (da) Injicerbar formulering
CL2014003283A1 (es) Formulación farmacéutica.
DK2815752T3 (da) Oral farmaceutisk sammensætning
DK2877155T3 (da) Opioidformuleringer
EP2883547A4 (en) MEDICINE
DK2854765T3 (da) Farmaceutisk pemetrexed-opløsning
EP2770828A4 (en) FORMULATION
ZA201405925B (en) Pharmaceutical formulation having improved stability
PT2908835T (pt) Formulações estáveis
CO7091176A2 (es) Diagnóstico farmacéutico
DK3473255T3 (da) Farmaceutisk formulering omfattende ciclesonid
DK3003401T3 (da) Farmaceutisk præparat
BR112015002646A2 (pt) composto e composição farmacêutica
PL2908836T3 (pl) Formulacja farmaceutyczna zawierająca kurkuminę
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
BR302012003979S1 (pt) Configuração aplicada em fármaco